COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

WY Chi, YD Li, HC Huang, TEH Chan, SY Chow… - Journal of biomedical …, 2022 - Springer
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …

Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects

Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …

A review of the safety and efficacy of current COVID-19 vaccines

Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

COVID‐19 vaccinations: the unknowns, challenges, and hopes

K Mohamed, P Rzymski, MS Islam… - Journal of medical …, 2022 - Wiley Online Library
The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …

Prospects for a safe COVID-19 vaccine

BF Haynes, L Corey, P Fernandes, PB Gilbert… - Science translational …, 2020 - science.org
Rapid development of an efficacious vaccine against the viral pathogen severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …

The way of SARS-CoV-2 vaccine development: success and challenges

Y Dong, T Dai, B Wang, L Zhang, LH Zeng… - … and Targeted Therapy, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 …

SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies

W Gong, S Parkkila, X Wu… - International reviews of …, 2023 - Taylor & Francis
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has become a global threat. Despite strict control measures …

Promise and challenges in the development of COVID-19 vaccines

W Chen - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an
unprecedented challenge to global public health system and biomedical community …

[HTML][HTML] COVID-19 challenges and its therapeutics

SU Rehman, SU Rehman, HH Yoo - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …